Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing Illumina's VeriSeq NIPT Solution v2 (Photo: Business ...
Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...
On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic. Following the announcement of the acquisition, Standard BioTools’ stock experienced a ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback